Mark Justin Iampietro

Title: Mark Justin Iampietro: Innovator in Recombinant Adenoviruses

Introduction

Mark Justin Iampietro is a notable inventor based in Boston, MA, who has made significant contributions to the field of biotechnology. He holds two patents that focus on recombinant adenoviruses, which are crucial for advancing medical treatments.

Latest Patents

Iampietro's latest patents revolve around recombinant adenoviruses and their applications. These adenoviruses, specifically simian (rhesus) adenoviruses, are characterized by their low seroprevalence and high immunogenicity when expressing antigenic polypeptides. His work includes methods for producing these adenoviruses and utilizing them in the treatment of diseases by administering the adenoviral vectors to subjects, including humans.

Career Highlights

Iampietro is affiliated with Beth Israel Deaconess Medical Center, Inc., where he continues to innovate in the field of medical research. His work has the potential to impact various therapeutic approaches, particularly in vaccine development and gene therapy.

Collaborations

Throughout his career, Iampietro has collaborated with esteemed colleagues such as Dan H Barouch and Peter Abbink. These partnerships have furthered research efforts and enhanced the development of his patented technologies.

Conclusion

Mark Justin Iampietro is a prominent figure in the realm of recombinant adenoviruses, with patents that hold promise for future medical advancements. His contributions to biotechnology are paving the way for innovative treatments and therapies.